Judge Robert Kirsch wrote that "clinical trials are complicated and nuanced, and investor calls are not scientific conferences." Get the market news that matters in a five-minute read with Market Briefs, our free daily newsletter Investors argue that Novo Nordisk's earlier communications glossed over this design feature, creating an expectation that nearly all participants would reach the highest dose and thus achieve maximum weight loss
The brand's site states candidates are "adults looking to support natural hormone production, or overall wellbeing," with the caveat that "your clinician will screen for safety and fit." That screening step matters - nothing here is guaranteed
Doi:10.1056/NEJMoa2032183 Davies M, Frch L, Jeppesen OK, et al
As a potent antioxidant, it helps neutralise free radicals that contribute to premature ageing
[10] Animal studies: studying receptor or pigment biology under an institutionally approved animal-use protocol